Back to Search Start Over

Functional pri-miR-34b/c rs4938723 and KRAS 3'UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome?

Authors :
Vieira IA
Pezzi EH
Bandeira IC
Reis LB
de Araújo Rocha YM
Fernandes BV
Siebert M
Miyamoto KN
Siqueira MB
Achatz MI
Galvão HCR
Garcia FAO
Campacci N
Carraro DM
Formiga MN
Vianna FSL
Palmero EI
Macedo GS
Ashton-Prolla P
Source :
Gene [Gene] 2024 Mar 10; Vol. 898, pp. 148069. Date of Electronic Publication: 2023 Dec 07.
Publication Year :
2024

Abstract

Purpose: Li-Fraumeni Syndrome (LFS) is a rare cancer predisposing condition caused by germline pathogenic TP53 variants, in which core tumors comprise sarcomas, breast, brain and adrenocortical neoplasms. Clinical manifestations are highly variable in carriers of the Brazilian germline founder variant TP53 p.R337H, possibly due to the influence of modifier genes such as miRNA genes involved in the regulation of the p53 pathway. Herein, we investigated the potential phenotypic effects of two miRNA-related functional SNPs, pri-miR-34b/c rs4938723 and 3'UTR KRAS rs61764370, in a cohort of 273 LFS patients from Southern and Southeastern Brazil.<br />Methods: The genotyping of selected SNPs was performed by TaqMan® allelic discrimination and subsequently custom TaqMan® genotyping results were confirmed by Sanger sequencing in all SNP-positive LFS patients.<br />Results: Although the KRAS SNP showed no effect as a phenotype modulator, the rs4938723 CC genotype was significantly associated with development of LFS non-core tumors (first tumor diagnosis) in p.R337H carriers (p = 0.039). Non-core tumors were also more frequently diagnosed in carriers of germline TP53 DNA binding domain variants harboring the rs4938723 C variant allele. Previous studies described pri-miR-34b/c rs4938723 C as a risk allele for sporadic occurrence of thyroid and prostate cancers (non-core tumors of the LFS spectrum).<br />Conclusion: With this study, we presented additional evidence about the importance of analyzing miRNA genes that could indirectly regulate p53 expression, and, therefore, may modulate the LFS phenotype, such as those of the miR-34 family.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Henrique de Campos Reis Galvao reports a relationship with AstraZeneca of Brazil that includes: speaking and lecture fees. Henrique de Campos Reis Galvao reports a relationship with Hermes Pardini Institute that includes: consulting or advisory.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1879-0038
Volume :
898
Database :
MEDLINE
Journal :
Gene
Publication Type :
Academic Journal
Accession number :
38070788
Full Text :
https://doi.org/10.1016/j.gene.2023.148069